Liver Cirrhosis, Biliary Clinical Trial
Official title:
Neuromuscular Electric Stimulation and Exercises Effect on Functional Exercise Performance and Quality of Life in Cases of Liver Cirrhosis
Patients with liver cirrhosis have severe physical deconditioning. Aim: To compare between the effect of neuromuscular electric stimulation(NMES) and exercises (EX)on treatment of patients with liver cirrhosis.
70 patients have been chosen from department of internal medicine, Cairo university hospitals, Egypt. 5 patients refused to participate .65 patients divided randomly into 2 groups. All the procedures were explained to patients.2 patients refused to sign informed consent and excluded from the study. 31 patients in group1 and 32 patients in group2. 1patients dropped in group1 and excluded from the study and two patients didn't continued the programmed treatment in group 2 and their data removed. Thirty patients in each group signed an informed consent and complete the treatment program. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02917408 -
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
|
||
Terminated |
NCT00550862 -
Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
|
Phase 2 | |
Completed |
NCT00004748 -
Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis
|
Phase 3 | |
Completed |
NCT03630718 -
Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women
|
N/A | |
Completed |
NCT00004842 -
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
|
Phase 1 | |
Terminated |
NCT03633227 -
Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
|
Phase 4 | |
Terminated |
NCT00125281 -
SAMe to Treat Biliary Cirrhosis Symptoms
|
Phase 2 | |
Completed |
NCT03468699 -
Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia
|
Phase 2 | |
Completed |
NCT00006168 -
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
|
Phase 3 | |
Completed |
NCT00004784 -
Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
|
Phase 3 | |
Completed |
NCT00570765 -
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
|
Phase 2 | |
Recruiting |
NCT00160940 -
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
|
N/A | |
Recruiting |
NCT03146910 -
Swiss Primary Biliary Cholangitis Cohort Study
|
||
Terminated |
NCT03265249 -
BRIDGE Device for Post-operative Pain Control
|
N/A | |
Terminated |
NCT02308111 -
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
|
Phase 4 | |
Recruiting |
NCT02936596 -
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
|
N/A | |
Completed |
NCT00406237 -
Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
|
Phase 1 | |
Completed |
NCT04047160 -
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
|
Phase 1 | |
Recruiting |
NCT00145964 -
Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
|
N/A | |
Terminated |
NCT03476993 -
Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis
|
Phase 2 |